Video

Assessing Psoriatic Arthritis Research For the Future

Author(s):

Philip Mease shared that he and his team are in the midst of preparing the content of the studies for publication to ensure continued education of psoriatic arthritis treatment.

Philip Mease shared that he and his team are in the midst of preparing the content of the studies for publication to ensure continued education about psoriatic arthritis treatment. Mease concluded, "We're very excited about this new data because this a patient population that historically has had few treatments at least until the anti-TNF medicines came along, and now we're finding that for patients who don't respond adequately to the anti-TNFs, it's important to have new mechanisms of action for treating this very important population of rheumatology patients."

Related Videos
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Julie Refardt, MD, PhD: Current Hyponatremia Clinical Interventions Sufficient
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action
Carla Nester, MD | Credit: HCPLive
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
© 2024 MJH Life Sciences

All rights reserved.